Biotech Values

[DewDiligence]

RMED reverse-merges with—(private)—Catheter Precision:

https://finance.yahoo.com/news/ra-medical-systems-enters-definitive-095000898.html

Catheter Precision stakeholders are expected to own approximately 80% of the combined company, and pre-merger Ra Medical equity holders are expected to own approximately 20% of the combined company, on a fully diluted basis…

…Catheter Precision is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.

Note: This PR is from 9/12/22.